5.00
price up icon3.09%   0.15
after-market Dopo l'orario di chiusura: 4.88 -0.12 -2.40%
loading

Perché le azioni Solid Biosciences Inc (SLDB) sono in ribasso?

Abbiamo notato un calo di 8.66% nelle azioni di Solid Biosciences Inc (SLDB) durante la sessione di negoziazione di 2024-11-15. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-17:

Shares of Solid Biosciences (SLDB) dropped by 5.51% from $2.72 to $2.57 in the trading on Friday, Novemeber 17, 2023. The reason why SLDB is down today is due to recent announcement from the company. Solid Biosciences announced that it had received FDA clearance for an Investigational New Drug (IND) application for its gene therapy candidate aimed at treating Duchenne muscular dystrophy. Despite this positive development, the stock price declined, possibly reflecting investor sentiment or broader market dynamics.

2023-11-16:

Shares of Solid Biosciences (SLDB) dropped by 5.51% from $2.72 to $2.57 in the trading on Friday, Novemeber 17, 2023. The reason why SLDB is down today is due to recent announcement from the company. Solid Biosciences announced that it had received FDA clearance for an Investigational New Drug (IND) application for its gene therapy candidate aimed at treating Duchenne muscular dystrophy. Despite this positive development, the stock price declined, possibly reflecting investor sentiment or broader market dynamics.

$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):